33 related articles for article (PubMed ID: 19998242)
1. Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.
Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):38-43. PubMed ID: 14758570
[TBL] [Abstract][Full Text] [Related]
2. Influence of fluor salts, hormone replacement therapy and calcitonin on the concentration of insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor-beta 1 in human iliac crest bone matrix from patients with primary osteoporosis.
Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
Eur J Endocrinol; 2004 Jan; 150(1):81-91. PubMed ID: 14713283
[TBL] [Abstract][Full Text] [Related]
3. Bone matrix insulin-like growth factor (IGF)-I, IGF-II and transforming growth factor (TGF)-beta1 levels in men and postmenopausal women with osteoporosis: lack of association with circulating growth factors and bone mineral density.
Georgescu C; Seck T; Diel I; Minne H; Duncea I; Pfeilschifter J
Rev Med Chir Soc Med Nat Iasi; 2004; 108(2):281-6. PubMed ID: 15688799
[TBL] [Abstract][Full Text] [Related]
4. Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1-84.
Recker RR; Bare SP; Smith SY; Varela A; Miller MA; Morris SA; Fox J
Bone; 2009 Jan; 44(1):113-9. PubMed ID: 18983947
[TBL] [Abstract][Full Text] [Related]
5. Skeletal response to recombinant human growth hormone (rhGH) in children treated with long-term corticosteroids.
Sanchez CP; Goodman WG; Brandli D; Goldenhersh M; Murray C; Carlton E; Hahn T; Salusky IB
J Bone Miner Res; 1995 Jan; 10(1):2-6. PubMed ID: 7747627
[TBL] [Abstract][Full Text] [Related]
6. Effect of glucocorticoid-, parathyroid- and thyroid hormones excess on human iliac crest bone matrix insulin-like growth factor (IGF)-I in patients with osteoporosis.
Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2010 May; 118(5):310-4. PubMed ID: 19998242
[TBL] [Abstract][Full Text] [Related]
7. Interactions between GH, IGF-I, glucocorticoids, and thyroid hormones during skeletal growth.
Robson H; Siebler T; Shalet SM; Williams GR
Pediatr Res; 2002 Aug; 52(2):137-47. PubMed ID: 12149488
[TBL] [Abstract][Full Text] [Related]
8. The dietary protein, IGF-I, skeletal health axis.
Bonjour JP
Horm Mol Biol Clin Investig; 2016 Oct; 28(1):39-53. PubMed ID: 26985688
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of impaired growth: effect of steroids on bone and cartilage.
Olney RC
Horm Res; 2009 Nov; 72 Suppl 1():30-5. PubMed ID: 19940493
[TBL] [Abstract][Full Text] [Related]
10. [Bone changes in thyrotoxicosis].
Ejima E; Fujiyama K; Kiriyama T; Eguchi K
Nihon Rinsho; 1998 Jun; 56(6):1587-90. PubMed ID: 9648486
[TBL] [Abstract][Full Text] [Related]
11. Effects of acidogenic diet forms on musculoskeletal function.
Jehle S; Krapf R
J Nephrol; 2010; 23 Suppl 16():S77-84. PubMed ID: 21170891
[TBL] [Abstract][Full Text] [Related]
12. Some basic aspects of bone metabolism in relation to osteoporosis.
Skosey JL
Med Clin North Am; 1970 Jan; 54(1):141-52. PubMed ID: 4904122
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
